2,436 research outputs found
Circulation
Spurred by advances in processing power, memory, storage, and an unprecedented wealth of data, computers are being asked to tackle increasingly complex learning tasks, often with astonishing success. Computers have now mastered a popular variant of poker, learned the laws of physics from experimental data, and become experts in video games - tasks that would have been deemed impossible not too long ago. In parallel, the number of companies centered on applying complex data analysis to varying industries has exploded, and it is thus unsurprising that some analytic companies are turning attention to problems in health care. The purpose of this review is to explore what problems in medicine might benefit from such learning approaches and use examples from the literature to introduce basic concepts in machine learning. It is important to note that seemingly large enough medical data sets and adequate learning algorithms have been available for many decades, and yet, although there are thousands of papers applying machine learning algorithms to medical data, very few have contributed meaningfully to clinical care. This lack of impact stands in stark contrast to the enormous relevance of machine learning to many other industries. Thus, part of my effort will be to identify what obstacles there may be to changing the practice of medicine through statistical learning approaches, and discuss how these might be overcome.K08 HL098361/HL/NHLBI NIH HHS/United StatesDP2 HL123228/DP/NCCDPHP CDC HHS/United StatesK08 HL093861/HL/NHLBI NIH HHS/United StatesU01 HL107440/HL/NHLBI NIH HHS/United StatesDP2 HL123228/HL/NHLBI NIH HHS/United States2018-03-01T00:00:00Z26572668PMC5831252vault:2743
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm
Cardiovascular disease (CVD) related mortality and morbidity heavily strain society. The relationship between external risk factors and our genetics have not been well established. It is widely acknowledged that environmental influence and individual behaviours play a significant role in CVD vulnerability, leading to the development of polygenic risk scores (PRS). We employed the PRISMA search method to locate pertinent research and literature to extensively review artificial intelligence (AI)-based PRS models for CVD risk prediction. Furthermore, we analyzed and compared conventional vs. AI-based solutions for PRS. We summarized the recent advances in our understanding of the use of AI-based PRS for risk prediction of CVD. Our study proposes three hypotheses: i) Multiple genetic variations and risk factors can be incorporated into AI-based PRS to improve the accuracy of CVD risk predicting. ii) AI-based PRS for CVD circumvents the drawbacks of conventional PRS calculators by incorporating a larger variety of genetic and non-genetic components, allowing for more precise and individualised risk estimations. iii) Using AI approaches, it is possible to significantly reduce the dimensionality of huge genomic datasets, resulting in more accurate and effective disease risk prediction models. Our study highlighted that the AI-PRS model outperformed traditional PRS calculators in predicting CVD risk. Furthermore, using AI-based methods to calculate PRS may increase the precision of risk predictions for CVD and have significant ramifications for individualized prevention and treatment plans
Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review
Cardiovascular disease (CVD) related mortality and morbidity heavily strain society. The relationship between external risk factors and our genetics have not been well established. It is widely acknowledged that environmental influence and individual behaviours play a significant role in CVD vulnerability, leading to the development of polygenic risk scores (PRS). We employed the PRISMA search method to locate pertinent research and literature to extensively review artificial intelligence (AI)-based PRS models for CVD risk prediction. Furthermore, we analyzed and compared conventional vs. AI-based solutions for PRS. We summarized the recent advances in our understanding of the use of AI-based PRS for risk prediction of CVD. Our study proposes three hypotheses: i) Multiple genetic variations and risk factors can be incorporated into AI-based PRS to improve the accuracy of CVD risk predicting. ii) AI-based PRS for CVD circumvents the drawbacks of conventional PRS calculators by incorporating a larger variety of genetic and non-genetic components, allowing for more precise and individualised risk estimations. iii) Using AI approaches, it is possible to significantly reduce the dimensionality of huge genomic datasets, resulting in more accurate and effective disease risk prediction models. Our study highlighted that the AI-PRS model outperformed traditional PRS calculators in predicting CVD risk. Furthermore, using AI-based methods to calculate PRS may increase the precision of risk predictions for CVD and have significant ramifications for individualized prevention and treatment plans
Machine learning in the social and health sciences
The uptake of machine learning (ML) approaches in the social and health
sciences has been rather slow, and research using ML for social and health
research questions remains fragmented. This may be due to the separate
development of research in the computational/data versus social and health
sciences as well as a lack of accessible overviews and adequate training in ML
techniques for non data science researchers. This paper provides a meta-mapping
of research questions in the social and health sciences to appropriate ML
approaches, by incorporating the necessary requirements to statistical analysis
in these disciplines. We map the established classification into description,
prediction, and causal inference to common research goals, such as estimating
prevalence of adverse health or social outcomes, predicting the risk of an
event, and identifying risk factors or causes of adverse outcomes. This
meta-mapping aims at overcoming disciplinary barriers and starting a fluid
dialogue between researchers from the social and health sciences and
methodologically trained researchers. Such mapping may also help to fully
exploit the benefits of ML while considering domain-specific aspects relevant
to the social and health sciences, and hopefully contribute to the acceleration
of the uptake of ML applications to advance both basic and applied social and
health sciences research
- …